Article Details

In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M

Retrieved on: 2018-01-01 18:52:30

Tags for this article:

Click the tags to see associated articles and topics

In an end-of-year IPO blitz, 4 biotechs pitch new offerings totaling $370M. View article details on hiswai:

Excerpt

<div>Celgene and Google's GV came back alongside Kleiner Perkins and OrbiMed as well as a broader syndicate including China's <b>Qiming Venture Partners</b> for the C round backing a new technology aimed at whipping up a more potent CD8-positive T cell attack on cancer cells — ground zero in the current ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up